Gene · 10128
Papers1,499
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,499
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The human mitochondrial mRNA structurome reveals mechanisms of gene expression. | Science | 2024 | 39024447 | PubTator, text mining | PubMed |
| Prognostic significance of LRPPRC and its association with immune infiltration in liver hepatocellular carcinoma. | Am J Clin Exp Immunol | 2024 | 39022790 | PubTator, text mining | PubMed |
| N6-methyladenosine methylation regulates the tumor microenvironment of Epstein-Barr virus-associated gastric cancer. | World J Gastrointest Oncol | 2024 | 38994134 | PubTator, text mining | PubMed |
| Correlation of disulfidptosis and periodontitis: New insights and clinical significance. | Arch Oral Biol | 2024 | 38991331 | PubTator, text mining | PubMed |
| Comprehensive analysis of disulfidptosis-related genes reveals the effect of disulfidptosis in ulcerative colitis. | Sci Rep | 2024 | 38977802 | PubTator, text mining | PubMed |
| FASTKD1 as a diagnostic and prognostic biomarker for STAD: Insights into m6A modification and immune infiltration. | Exp Ther Med | 2024 | 38873045 | PubTator, text mining | PubMed |
| Identification of Key Disulfidptosis-Related Genes and Their Association with Gene Expression Subtypes in Crohn's Disease. | J Inflamm Res | 2024 | 38863903 | PubTator, text mining | PubMed |
| A Comprehensive Prognostic Model for Colon Adenocarcinoma Depending on Nuclear-Mitochondrial-Related Genes. | Technol Cancer Res Treat | 2024 | 38832431 | PubTator, text mining | PubMed |
| Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis. | Front Immunol | 2024 | 38707900 | PubTator, text mining | PubMed |
| Human induced pluripotent stem cells (hiPSCs) derived cells reflect tissue specificity found in patients with Leigh syndrome French Canadian variant (LSFC). | Front Genet | 2024 | 38706791 | PubTator, text mining | PubMed |
| Targeting leucine-rich PPR motif-containing protein/LRPPRC by 5,7,4'-trimethoxyflavone suppresses esophageal squamous cell carcinoma progression. | Int J Biol Macromol | 2024 | 38697422 | PubTator, text mining | PubMed |
| Gossypol acetic acid regulates leukemia stem cells by degrading LRPPRC via inhibiting IL-6/JAK1/STAT3 signaling or resulting mitochondrial dysfunction. | World J Stem Cells | 2024 | 38690512 | PubTator, text mining | PubMed |
| M6A-related bioinformatics analysis indicates that LRPPRC is an immune marker for ischemic stroke. | Sci Rep | 2024 | 38632288 | PubTator, text mining | PubMed |
| Methylated lncRNAs suppress apoptosis of gastric cancer stem cells via the lncRNA-miRNA/protein axis. | Cell Mol Biol Lett | 2024 | 38600465 | PubTator, text mining | PubMed |
| A kinetic dichotomy between mitochondrial and nuclear gene expression processes. | Mol Cell | 2024 | 38503286 | PubTator, text mining | PubMed |
| Construction and validation of m6A-related diagnostic model for psoriasis. | PeerJ | 2024 | 38436011 | PubTator, text mining | PubMed |
| Comprehensive pan-cancer analysis identifies the RNA-binding protein LRPPRC as a novel prognostic and immune biomarker. | Life Sci | 2024 | 38417544 | PubTator, text mining | PubMed |
| Comprehensive analysis of m6A RNA methylation regulators in esophageal carcinoma. | Transl Cancer Res | 2024 | 38410211 | PubTator, text mining | PubMed |
| LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m6 A modification in triple-negative breast cancer. | Clin Transl Med | 2024 | 38372449 | PubTator, text mining | PubMed |
| Analysis of m6A regulators related immune characteristics in ankylosing spondylitis by integrated bioinformatics and computational strategies. | Sci Rep | 2024 | 38302672 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10128/papers?page=6